Quantum biochemistry description of PI3Kα enzyme bound to selective inhibitors

被引:0
|
作者
de Sousa, Francisca Joseli Freitas [1 ]
Azevedo, Francisca Fernanda Nunes [1 ]
de Oliveira, Francisco Lucas Santos [2 ]
Carletti, Jaqueline Vieira [3 ]
Freire, Valder Nogueira [4 ]
Zanatta, Geancarlo [1 ,2 ]
机构
[1] Univ Fed Ceara, Dept Biochem & Mol Biol, Fortaleza, Brazil
[2] Univ Fed Rio Grande do Sul, Dept Biophys, Porto Alegre, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, Brazil
[4] Univ Fed Ceara, Dept Phys, Fortaleza, Brazil
关键词
Alpelisib; GDC-0326; PI3K alpha-inhibitors; phosphoinositide-3-kinase; molecular fragmentation with conjugated caps; quantum calculation; POPULATION ANALYSIS; INFORMATION-THEORY; ISOFORM; IDENTIFICATION; MECHANICS; BINDING; DESIGN; NVP-BYL719; MOLECULES; DISCOVERY;
D O I
10.1080/07391102.2023.2251063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The PI3K class I is composed of four PI3K isoforms that serve as regulatory enzymes governing cellular metabolism, proliferation, and survival. The hyperactivation of PI3K alpha is observed in various types of cancer and is linked to poor prognosis. Unfortunately, the development inhibitors selectively targeting one of the isoforms remains challenging, with only few agents in clinical use. The main difficulty arises from the high conservation among residues at the ATP-binding pocket across isoforms, which also serves as target pocket for inhibitors. In this work, molecular dynamics and quantum calculations were performed to investigate the molecular features guiding the binding of selective inhibitors, alpelisib and GDC-0326, into the ATP-binding pocket of PI3K alpha. While molecular dynamics allowed crystallographic coordinates to relax, the interaction eergy between each amino acid residues and inhibitors was obtained by combining the Molecular Fractionation with Conjugated Caps scheme with Density Functional Theory calculations. In addition, the atomic charge of ligands in the bound and unbound (free) was calculated. Results indicated that the most relevant residues for the binding of alpelisib are Ile932, Glu859, Val851, Val850, Tyr836, Met922, Ile800, and Ile848, while the most important residues for the binding of GDC-0326 are Ile848, Ile800, Ile932, Gln859, Glu849, and Met922. In addition, residues Trp780, Ile800, Tyr836, Ile848, Gln859 Val850, Val851, Ile932 and Met922 are common hotspots for both inhibitors. Overall, the results from this work contribute to improving the understanding of the molecular mechanisms controlling selectivity and highlight important interactions to be considered during the rational design of new agents.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Quantum biochemistry description of PI3Ka enzyme bound to selective inhibitors
    de Sousa, Francisca Joseli Freitas
    Azevedo, Francisca Fernanda Nunes
    de Oliveira, Francisco Lucas Santos
    Carletti, Jaqueline Vieira
    Freire, Valder Nogueira
    Zanatta, Geancarlo
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
  • [2] Designing selective PI3K inhibitors
    Sarah Crunkhorn
    [J]. Nature Reviews Drug Discovery, 2010, 9 : 105 - 105
  • [3] Designing selective PI3K inhibitors
    Crunkhorn, Sarah
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (02) : 105 - 105
  • [4] Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels
    Dan, Shingo
    Sugita, Hironobu
    Yamazaki, Kanami
    Yamori, Takao
    [J]. CANCER RESEARCH, 2009, 69
  • [5] Discovery of Potent and Selective PI3Kγ Inhibitors
    Drew, Samuel L.
    Thomas-Tran, Rhiannon
    Beatty, Joel W.
    Fournier, Jeremy
    Lawson, Kenneth, V
    Miles, Dillon H.
    Mata, Guillaume
    Sharif, Ehesan U.
    Yan, Xuelei
    Mailyan, Artur K.
    Ginn, Elaine
    Chen, Jie
    Wong, Kent
    Soni, Divyank
    Dhanota, Puja
    Chen, Pei-Yu
    Shaqfeh, Stefan G.
    Meleza, Cesar
    Pham, Amber T.
    Chen, Ada
    Zhao, Xiaoning
    Banuelos, Jesus
    Jin, Lixia
    Schindler, Ulrike
    Walters, Matthew J.
    Young, Stephen W.
    Walker, Nigel P.
    Leleti, Manmohan Reddy
    Powers, Jay P.
    Jeffrey, Jenna L.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11235 - 11257
  • [6] Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors
    Ma, Chen-Chen
    Zhang, Cheng-Mei
    Tang, Long-Qian
    Liu, Zhao-Peng
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 9 - 17
  • [7] Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors
    Jia, Hong
    Dai, Guangxiu
    Su, Weiguo
    Xiao, Kun
    Weng, Jianyang
    Zhang, Zhulin
    Wang, Qing
    Yuan, Tianhai
    Shi, Fuying
    Zhang, Zheng
    Chen, Wei
    Sai, Yang
    Wang, Jian
    Li, Xiong
    Cai, Yu
    Yu, Jun
    Ren, Ping
    Venable, Jennifer
    Rao, Tadimeti
    Edwards, James P.
    Bembenek, Scott D.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4936 - 4948
  • [8] Development of PI3Kγ selective inhibitors: the strategies and application
    Gu, Dong-Yan
    Zhang, Meng-Meng
    Li, Jia
    Zhou, Yu-Bo
    Sheng, Rong
    [J]. ACTA PHARMACOLOGICA SINICA, 2024, 45 (02) : 238 - 247
  • [9] Development of novel, selective and irreversible PI3Kδ inhibitors
    Dalton, Samuel
    Campos, Sebastien
    Bush, Jacob
    Thomas, Daniel
    Convery, Maire
    Murphy, John
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [10] Selective PI3Kδ inhibitors, a review of the patent literature
    Norman, Peter
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (11) : 1773 - 1790